SEC Form 4 · accession 0001628280-26-053512
Camp4 Therapeutics Corp · CAMP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Yuri Maricich
Officer — Chief Medical Officer
Period of report
Aug 3, 2026
Accepted (ET)
Aug 5, 2026 · 5:08 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001736730
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 3, 2026 | P | 6,551 | $1.65 | A | 12,611 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On August 3, 2026, the reporting person acquired shares in the second closing of a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement, dated as of September 9, 2025, as amended on August 3, 2026, by and among the Issuer and certain institutional investors and certain directors, employees, and consultants, at a purchase price of $1.65 per share.